Who is sponsoring NCT03263728?

NCT03263728 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT03263728?

Interventions in NCT03263728: Cardiac Magnetic Resonance.

What condition does NCT03263728 study?

NCT03263728 studies Diabetes Mellitus, Type 2, Coronary Artery Disease.

Is NCT03263728 still recruiting?

NCT03263728 is currently completed. Last updated 20 August 2019.

Last reviewed 2019-08-20 · How we verify

NCT03263728: CATCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiac Magnetic Resonance for Asymptomatic Type 2 Diabetics With Cardiovascular High Risk (CATCH) - Pilot Study

Completed NA Last updated 20 August 2019

What this trial tests

NA trial testing Cardiac Magnetic Resonance in Diabetes Mellitus, Type 2 in 63 participants. Completed in 29 January 2019.

Timeline

10 August 2017

Primary endpoint
29 January 2019

29 January 2019

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	63
Start date	10 August 2017
Primary completion	29 January 2019
Estimated completion	29 January 2019
Sites	1 location across Hong Kong

Drugs / interventions tested

Cardiac Magnetic Resonance

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

The University of Hong Kong

Who can join

Adults 60 to 80, any sex, with Diabetes Mellitus, Type 2 or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the prevalence of myocardial ischaemia in asymptomatic high risk type 2 diabetic patients using stress cardiac MR and how many stress cardiac MR examinations are false positive.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study.
Ng MY, Zhou W, Vardhanabhuti V, Lee CH, et al · · 2020 · cited 11× · PMID 32234045 · DOI 10.1186/s12933-020-01019-2

Verify or expand the search:

Other trials of Cardiac Magnetic Resonance

Trials testing the same drug.

NCT06020209 — CCT for Comprehensive Risk Stratification Following STEMI · NA · recruiting
NCT05006443 — Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques · NA · completed
NCT04880317 — Validation of Quantitative Myocardial Tissue Characterization Through Non-gated CT · NA · terminated
NCT03415789 — Intraventricular Stasis in Non Ischemic Dilated Myocardiopathy · completed
NCT03525639 — CMR Evaluation of Myocardial Inflammation Persistence After Acute Myocarditis: Prognostic Relevance · NA · completed

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03263728 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 20 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03263728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing